Get started
Author

J. C. Boughey

Observed names: J. Boughey, J.C. Boughey
OpenAlex ID: A5141104142
Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial
2026 · J. Tseng, K. Dimitroff, et al. · Annals of Surgical Oncology · 1
PDF
Correction: ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial
2026 · J. Tseng, K. Dimitroff, et al. · Annals of Surgical Oncology
PDF
Correction: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial
2026 · J. Tseng, K. Dimitroff, et al. · Annals of Surgical Oncology
PDF
ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial
2026 · J. Tseng, K. Dimitroff, et al. · Annals of Surgical Oncology
ASO Author Reflections: Young Women with Breast Cancer may Safely Opt for Breast Conservation After Neoadjuvant Therapy
2026 · J. Tseng, J. C. Boughey, et al. · Annals of Surgical Oncology
PDF
Abstract PD6-09: Quantifying the Contribution of Doxorubicin and Cyclophosphamide (AC) to Pathologic Response Following Neoadjuvant Taxane Therapy: Analysis of the I-SPY2 TRIAL
2026 · D. Yee, C. Yau, et al. · Clinical Cancer Research
Abstract PS1-01-09: Real-time monitoring for drug-induced interstitial lung disease with Trastuzumab Deruxtecan and Rilvegostomig combination therapy prevents persistent, symptomatic disease: Safety insights from the I-SPY2.2 platform trial
2026 · T. Kulkarni, R. Nanda, et al. · Clinical Cancer Research
Abstract RF5-06: Pathologic complete response rates (pCR) after the novel HER2 ADC ARX788: Results from the I-SPY2.2 trial
2026 · P. R. Pohlmann, H. S. Rugo, et al. · Clinical Cancer Research
Abstract PS5-12-16: A Phase 2 Trial of (Z)-endoxifen + Goserelin as Neoadjuvant Treatment for Premenopausal Women with ER+, HER2-, Breast Cancer (EVANGELINE)
2026 · M. P. Goetz, V. J. Suman, et al. · Clinical Cancer Research
Abstract PS3-07-10: Low dose (Z)-endoxifen in the I-SPY2 Endocrine Optimization Pilot
2026 · K. V. Giridhar, M. P. Goetz, et al. · Clinical Cancer Research
Long-Term Outcome of Novel Intraoperatively-Placed Brachytherapy for Rapid Completion of Breast Conserving Therapy
2022 · H. Kim, R.W. Mutter, et al. · International Journal of Radiation Oncology*Biology*Physics
Breast Reconstruction Outcomes with Immediate Reconstruction Followed by Proton or Photon Postmastectomy Radiotherapy
2022 · R.W. Gao, W.S. Harmsen, et al. · International Journal of Radiation Oncology*Biology*Physics
Ultra-Accelerated Photons, Protons or Brachytherapy for Favorable Early Breast Cancer: Long-Term Results of a 3-Fraction Partial Breast Irradiation Trial
2022 · R.W. Mutter, M.A. Golafshar, et al. · International Journal of Radiation Oncology*Biology*Physics
Works count: 13
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type